COMPARISON BETWEEN QT-INTERVAL PARAMETERS IN TYPE 2 DIABETIC AND NON-DIABETIC PATIENTS IN NON-ST SEGMENT ELEVATION MI
DOI:
https://doi.org/10.71000/ajsxc087Keywords:
QT dispersion, QT interval, NSTEMI, Cardiac electrophysiology, , Diabetic patients, Electrocardiography, , Myocardial infarctionAbstract
Background: Diabetes mellitus is known to increase cardiovascular risk and exacerbate complications during acute coronary events. QT interval abnormalities have been linked to adverse cardiac outcomes, particularly in diabetic individuals. Evaluating QT interval parameters in patients with non-ST segment elevation myocardial infarction (NSTEMI) may offer valuable insight into arrhythmic risk and guide clinical decision-making. This study aimed to compare QT interval characteristics between type 2 diabetic and non-diabetic patients presenting with NSTEMI to better understand this electrophysiological interplay.
Objective: To compare QT-interval parameters in type 2 diabetic and non-diabetic patients with NSTEMI.
Methods: This quasi-experimental study was conducted at the Department of Cardiology, Khyber Teaching Hospital, Peshawar, over a six-month period from July 11, 2024, to January 10, 2025. A total of 58 patients aged 35 to 80 years diagnosed with NSTEMI were enrolled and categorized into two groups: diabetic (n=29) and non-diabetic (n=29). Type 2 diabetes status was confirmed using HbA1c (>6.5% for diabetics, <5.5% for non-diabetics). A standard 12-lead ECG was obtained from all participants. QT max, QT min, QTc max, QTc min, QT dispersion (QTd), and corrected QT dispersion (QTcd) were measured. Mean values were compared between the groups using an independent samples t-test. SPSS version 26.0 was used for data analysis.
Results: QTd was significantly higher in diabetics (47.31 ± 7.74 ms) than in non-diabetics (38.83 ± 5.78 ms, p<0.001). QTc min was also significantly prolonged in diabetics (53.00 ± 8.62 ms) compared to non-diabetics (41.58 ± 6.54 ms, p<0.001). QTc max showed a non-significant elevation in diabetics (425.83 ± 36.52 ms) versus non-diabetics (414.83 ± 19.21 ms, p=0.157). QTcd values were higher in diabetics (372.82 ± 37.49 ms) than non-diabetics (373.24 ± 22.90 ms) but not statistically significant (p=0.960).
Conclusion: QT interval parameters, particularly QTd and QTc min, were significantly prolonged in diabetic patients with NSTEMI, suggesting a heightened risk of ventricular repolarization disturbances in this group. These findings support the use of ECG-based QT metrics for enhanced risk stratification in diabetic cardiac patients.
References
Akutsu Y, Li HL, Shinozuka A, Kodama Y, Yamanaka H, Katagiri T, et al. Change with exercise in QT dispersion in infarct-related myocardium after angioplasty. Int J Cardiol 2020; 99:105–11.
Wranicz JK, Ruta J, Strzondała M, Kośmider M, Bolińska H, Zasłonka J, et al. QT interval duration in 24-hour Holter monitoring after different interventional treatment of coronary artery disease in patients after the myocardial infarction. Med Sci Monit 2020; 6:100–2.
Davey P. QT interval and mortality from coronary artery disease. Prog Cardiovasc Dis 2020:42:359–84.
Robbins J. The Association between the length of the QT interval and mortality in the cardiovascular health study. Am J Med 2023:115:689–94.
van Dam RM. The epidemiology of lifestyle and risk for type 2 diabetes. Eur J Epidemiol 2023; 18:115–20.
Cho E, Rimm EB, Stampfer MJ, Willett WC, Hu FB. The impact of diabetes mellitus and prior myocardial infarction on mortality from all causes and from coronary heart disease in men. J Am Coll Cardiol 2022; 40: 954–960.
Takebayashi K, Sugita R, Tayama K, Aso Y, Takemura Y, Inukai T. The connection between QT dispersion and autonomic neuropathy in patients with type 2 diabetes. Exp Clin Endocrinol Diabetes 2023; 111: 351–357.
Takahashi N, Nakagawa M, Saikawa T, Watanabe M, Ooie T, Yufu K, Shigematsu S, Hara M, Sakino H, Katsuragi I, Tanaka K, Yoshimatsu H. Regulation of QT indices mediated by autonomic nervous function in patients with type 2 diabetes. Int J Cardiol 2024; 96: 375–379.
Marfella R, Rossi F, Giugliano D. Hyperglycemia and QT interval: time for re-evaluation. Diabetes Nutr Metab 2021; 14: 63–65.
Bountioukos M, Schinkel AF, Poldermans D, Rizzello V, Vourvouri EC, Krenning BJ, Biagini E, Roelandt JR, Bax JJ. QT dispersion correlates to myocardial viability assessed by dobutamine stress echocardiography in patients with severely depressed left ventricular function due to coronary artery disease. Eur J Heart Fail 2024; 6: 187–193.
Hashimoto N, Musha H, Ozawa A, Imai Y, Kawasaki K, Miyazu O, Nagashima J, So T, Miyake F, Murayama M. Relationship between infarction location and size to QT dispersion in patients with chronic myocardial infarction. Jpn Heart J 2022; 43: 455–461.
Rana BS, Band MM, Ogston S, Morris AD, Pringle SD, Struthers AD. Relation of QT interval dispersion to the number of different cardiac abnormalities in diabetes mellitus. Am J Cardiol 2022; 90: 483–487.
Ahmed AS, Mona MM, Abdel-Kareem MA, Elsisy RA. SGLT2 inhibitor empagliflozin monotherapy alleviates renal oxidative stress in albino Wistar diabetic rats after myocardial infarction induction. Biomed Pharmacother. 2021;139:111624.
Naik E, Dongarwar D, Leonelli F, Foulis P, Leaverton P, Le C, et al. Risk of Silent Myocardial Infarction in Prediabetic Patients: A Case-Control Study in a Veteran Population. South Med J. 2021;114(7):419-23.
Fontes Oliveira M, Costa R, Frias A, Santos R, Brochado B, Santos M, et al. Pre-infarction angina is associated with improved prognosis in diabetic patients with ST-elevation myocardial infarction - data from a contemporary cohort. Coron Artery Dis. 2021;32(5):375-81.
Ge Y, He D, Shao Y, Wang L, Yan W. Percutaneous coronary intervention in insulin-treated diabetic patients: A meta-analysis. Ann Noninvasive Electrocardiol. 2022;27(5):e12953.
Borowicz A, Nadolny K, Bujak K, Cieśla D, Gąsior M, Hudzik B. Paramedic versus physician-staffed ambulances and prehospital delays in the management of patients with ST-segment elevation myocardial infarction. Cardiol J. 2021;28(1):110-7.
Hadad R, Larsen BS, Weber P, Stavnem D, Kristiansen OP, Nielsen OW, et al. Night-time heart rate variability identifies high-risk people among people with uncomplicated type 2 diabetes mellitus. Diabet Med. 2021;38(7):e14559.
Nijpels G, van der Heijden A, Elders P, Beulens JWJ, de Vet HCW. The interobserver agreement of ECG abnormalities using Minnesota codes in people with type 2 diabetes. PLoS One. 2021;16(8):e0255466.
Wan J, Zhang Q, Xu F, Jiang X, Chen C, Pan X, et al. Effects of SGLT2 inhibitors on cardiac autonomic activity and ventricular remodeling in patients with acute myocardial infarction: study protocol for a clinical trial. Trials. 2025;26(1):246.
Shimizu W, Kubota Y, Hoshika Y, Mozawa K, Tara S, Tokita Y, et al. Effects of empagliflozin versus placebo on cardiac sympathetic activity in acute myocardial infarction patients with type 2 diabetes mellitus: the EMBODY trial. Cardiovasc Diabetol. 2020;19(1):148.
Tomasik A, Nabrdalik K, Kwiendacz H, Radzik E, Pigoń K, Młyńczak T, et al. Effect of Diabetes Mellitus and Left Ventricular Perfusion on Frequency of Development of Heart Failure and/or All-cause Mortality Late After Acute Myocardial Infarction. Am J Cardiol. 2021;140:25-32.
Popescu S, Heeger CH, Kuck KH, Tilz RR. Diagnosis and Management of Left Ventricular Perforation During Mapping of Ventricular Tachycardia. Am J Case Rep. 2021;22:e930381.
Kong M, Liu F, Zhu Z. Analysis between high risk of myocardial infarction with non-obstructive coronary artery disease in single center and occurrence of major adverse cardiovascular events. Ann Noninvasive Electrocardiol. 2022;27(6):e13007.
Schmitz T, Thilo C, Linseisen J, Heier M, Peters A, Kuch B, et al. Admission ECG changes predict short term-mortality after acute myocardial infarction less reliable in patients with diabetes. Sci Rep. 2021;11(1):6307.
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Kamran Khan, Saima Humayun (Author)
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
